UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017940
Receipt No. R000020762
Official scientific title of the study Comparison of the influences of Sevoflurane or Desflurane on the postoperative state of pediatric general anesthesia
Date of disclosure of the study information 2015/07/01
Last modified on 2016/06/17 (Ver. 10)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Comparison of the influences of Sevoflurane or Desflurane on the postoperative state of pediatric general anesthesia
Title of the study (Brief title) The influences of Sevoflurane and Desflurane on the postoperative state of pediatric general anesthesia
Region
Japan

Condition
Condition pediatic surgery(inguinal hernia, umbilical hernia)
otolaryngological surgery(tonsillar hypertrophy, adenoidal hypertrophy, otitis media)
Classification by specialty
Pediatrics Oto-rhino-laryngology Anesthesiology
Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare Desflurane with Sevoflurane for the postoperative quality and possible side effects of pediatric general anesthesia
Basic objectives2 Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Assessment of the quality during emergence period(agitation, nausea, vomiting)
Key secondary outcomes Assessment of the quality at the point of one hour after returning the ward (agitation, nausea, vomiting)

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 We randomly assign twenty children who undergo pediatric or otolaryngological surgery with 1-6% Sevoflurane at the induction and maintenance of anesthesia.
Interventions/Control_2 We randomly assign twenty children who undergo pediatric or otolaryngological surgery with 1-6% Sevoflurane at the induction and switched to 3-6% Desflurane at the maintenance of anesthesia.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
6 years-old >=
Gender Male and Female
Key inclusion criteria children 1-6 years old who receives an elective pediatric or otolaryngological surgery
Key exclusion criteria ASA-PS(ASA physical status)>3 or 4, asthma, body weight>25kg
Target sample size 40

Research contact person
Name of lead principal investigator Tomoaki Urabe
Organization Hiroshima Prefectural Hospital
Division name Anesthesiology
Address 1-5-54 Ujinakanda, Minamiku, Hiroshima-city, Hiroshima-prefecture, Japan 734-8530
TEL 082-3260-5203
Email tomoakiurabe@gmail.com

Public contact
Name of contact person Tomoaki Urabe
Organization Hiroshima Prefectural Hospital
Division name Anesthesiology
Address 1-5-54 Ujinakanda, Minamiku, Hiroshima-city, Hiroshima-prefecture, Japan 734-8530
TEL 082-254-1818
Homepage URL
Email t-yoshimura87638@pref.hiroshima.lg.jp

Sponsor
Institute Hiroshima Prefectural Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 県立広島病院 手術室(広島県)

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 06 Month 30 Day
Anticipated trial start date
2015 Year 07 Month 01 Day
Last follow-up date
2015 Year 11 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 06 Month 17 Day
Last modified on
2016 Year 06 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020762